Prognostic Value of Circulating Regulatory T Cells for Worsening Heart Failure in Heart Failure Patients With Reduced Ejection Fraction
Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduce...
Saved in:
Published in | International Heart Journal Vol. 55; no. 3; pp. 271 - 277 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
International Heart Journal Association
2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1349-2365 1349-3299 |
DOI | 10.1536/ihj.13-343 |
Cover
Abstract | Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduced ejection fraction (HF-REF). The study population consisted of 32 HF-REF patients who were hospitalized for worsening HF, and 18 control subjects. Cardiac function was evaluated by echocardiography. A single venous blood sample was collected before discharge. Circulating T cells were evaluated by flow cytometry. Tregs were defined as CD4+CD25+Foxp3+T cells, and the correlations between the frequency of Tregs and CRP, IL-6 and several echoparameters were analysed. Furthermore, all HF-REF patients were followed up to 12 months from discharge to examine the predictors of recurrent hospitalization. In HF-REF patients, Tregs were significantly decreased (5.9 ± 1.4 versus 8.0 ± 2.2%, P < 0.01), while CD4+HLADR+T cells were increased (10.1 ± 5.4 versus 7.3 ± 3.1%, P < 0.05), compared with controls. Tregs were negatively correlated with left ventricular end-diastolic dimension, and levels of CRP and IL-6. Eleven of 32 HF-REF patients were rehospitalized for worsening HF within 12 months. Multivariate Cox regression analysis showed that CD4/CD8 and frequency of Tregs were independent predictors for recurrent hospitalization. Furthermore, HF-REF patients expressing under 6% Treg/CD4+T cells showed a significantly higher incidence of recurrent hospitalization for worsening HF within 12 months. Our data suggest that Tregs might be involved in the pathogenesis of decompensated HF, and may be a novel predictor of poor prognosis in HF-REF patients. |
---|---|
AbstractList | Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduced ejection fraction (HF-REF). The study population consisted of 32 HF-REF patients who were hospitalized for worsening HF, and 18 control subjects. Cardiac function was evaluated by echocardiography. A single venous blood sample was collected before discharge. Circulating T cells were evaluated by flow cytometry. Tregs were defined as CD4(+)CD25(+)Foxp3(+)T cells, and the correlations between the frequency of Tregs and CRP, IL-6 and several echoparameters were analysed. Furthermore, all HF-REF patients were followed up to 12 months from discharge to examine the predictors of recurrent hospitalization.In HF-REF patients, Tregs were significantly decreased (5.9 ± 1.4 versus 8.0 ± 2.2%, P < 0.01), while CD4(+)HLADR(+)T cells were increased (10.1 ± 5.4 versus 7.3 ± 3.1%, P < 0.05), compared with controls. Tregs were negatively correlated with left ventricular end-diastolic dimension, and levels of CRP and IL-6. Eleven of 32 HF-REF patients were rehospitalized for worsening HF within 12 months. Multivariate Cox regression analysis showed that CD4/CD8 and frequency of Tregs were independent predictors for recurrent hospitalization. Furthermore, HF-REF patients expressing under 6% Treg/CD4(+)T cells showed a significantly higher incidence of recurrent hospitalization for worsening HF within 12 months.Our data suggest that Tregs might be involved in the pathogenesis of decompensated HF, and may be a novel predictor of poor prognosis in HF-REF patients. |
Author | Noma, Takahisa Murakami, Kazushi Oomizu, Souichi Yamaoka, Genji Okamoto, Naoko Takabatake, Wataru Ishizawa, Makoto Ishihara, Yasuhiro Ohmori, Koji Kohno, Masakazu Miyauchi, Yuka Iwado, Yasuyoshi Namba, Tsunetatsu |
Author_xml | – sequence: 1 fullname: Miyauchi, Yuka organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Okamoto, Naoko organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Ishihara, Yasuhiro organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Kohno, Masakazu organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Murakami, Kazushi organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Noma, Takahisa organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Oomizu, Souichi organization: Department of Immunology, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Namba, Tsunetatsu organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Iwado, Yasuyoshi organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Ohmori, Koji organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Takabatake, Wataru organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Ishizawa, Makoto organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University – sequence: 1 fullname: Yamaoka, Genji organization: Department of Clinical Laboratory, Faculty of Medicine, Kagawa University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24814327$$D View this record in MEDLINE/PubMed |
BookMark | eNptkM1OwzAQhC0EAlq48ADIZ6RAnE2a-AaqKEWqRIX4OUaus25dpTaynUOfgNcmaaCHisvuyP5mpJ0BOTbWICFXLL5lGYzu9Gp9yyCCFI7IOYOUR5BwfvyrExhlZ2Tg_TqOU5bF-Sk5S9KCpZDk5-R77uzSWB-0pB-ibpBaRcfayaYWQZslfcVlJ63b0jc6xrr2VFlHP63zaDpgisIFOhG6bhxSbQ4e5m0MmuDppw6rNq1qJFb0cY0yaGvoxImduCAnStQeL3_3kLxPHt_G02j28vQ8fphFMs3jEKmi4FymiSy4qJTIGTBeAVSq4hmTjBUAC5HHPGUqERJZobjgnONIJlzhQsKQXPe5X81ig1X55fRGuG3510gL3PSAdNZ7h2qPsLjs6i7buksGZVt3C8cHsNRBdPcE197_v-W-t6x9EEvcp7edaVnjDs2yErrRW_ZfciVciQZ-AE4xm-Q |
CitedBy_id | crossref_primary_10_3389_fimmu_2021_732794 crossref_primary_10_1155_2016_4396368 crossref_primary_10_3390_nu16040546 crossref_primary_10_7717_peerj_15893 crossref_primary_10_1161_CIRCRESAHA_116_310342 crossref_primary_10_1007_s10557_017_6752_z crossref_primary_10_3390_ijms25052667 crossref_primary_10_1007_s11596_018_1866_5 crossref_primary_10_1097_CM9_0000000000002875 crossref_primary_10_3390_jpm10020039 crossref_primary_10_1016_j_carpath_2024_107635 crossref_primary_10_1038_s41419_018_1209_2 crossref_primary_10_1016_j_jacbts_2023_03_015 crossref_primary_10_1016_j_lfs_2022_120392 crossref_primary_10_3389_fimmu_2022_914033 crossref_primary_10_3390_biom13101535 crossref_primary_10_1016_j_pharmthera_2016_03_006 crossref_primary_10_3389_fcvm_2022_993142 crossref_primary_10_3920_BM2016_0119 crossref_primary_10_1007_s11936_018_0617_z crossref_primary_10_1177_2047487319870344 crossref_primary_10_3390_biomedicines11041029 crossref_primary_10_3390_medicina57020176 crossref_primary_10_1155_2018_4396351 crossref_primary_10_1038_nrcardio_2015_169 crossref_primary_10_3390_biomedicines10112712 crossref_primary_10_3390_jcdd9020063 crossref_primary_10_1093_cvr_cvac142 crossref_primary_10_1002_ehf2_12744 crossref_primary_10_1111_anec_12781 crossref_primary_10_1096_fj_202400839R crossref_primary_10_3389_fphys_2021_695047 crossref_primary_10_1186_s13287_022_03101_w crossref_primary_10_1093_labmed_lmz049 crossref_primary_10_3892_etm_2017_4202 crossref_primary_10_1152_ajpheart_00028_2019 crossref_primary_10_1161_ATVBAHA_119_312287 crossref_primary_10_3389_fcvm_2024_1430477 |
Cites_doi | 10.1111/j.0105-2896.2005.00231.x 10.1126/science.1160062 10.1016/j.cyto.2009.09.007 10.1016/j.jbspin.2008.08.002 10.1182/blood-2003-11-3900 10.1002/eji.201040558 10.1161/01.CIR.0000147611.92021.2B 10.1161/01.CIR.88.1.107 10.4049/jimmunol.176.8.4622 10.1007/s10741-012-9352-9 10.4049/jimmunol.155.3.1151 10.1016/j.amjcard.2005.03.006 10.1161/CIRCULATIONAHA.104.508465 10.1016/S0008-6363(03)00362-6 10.1016/j.jacc.2007.02.037 10.1016/S0140-6736(00)04560-8 10.1084/jem.20030152 10.1038/nature04753 10.1038/ni1105-1069 10.1016/j.ahj.2003.07.023 10.1056/NEJM199108013250501 10.1159/000303050 10.1161/CIRCULATIONAHA.108.832782 10.1536/ihj.52.382 10.1093/eurheartj/ehi631 |
ContentType | Journal Article |
Copyright | 2014 by the International Heart Journal Association |
Copyright_xml | – notice: 2014 by the International Heart Journal Association |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM |
DOI | 10.1536/ihj.13-343 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-3299 |
EndPage | 277 |
ExternalDocumentID | 24814327 10_1536_ihj_13_343 article_ihj_55_3_55_13_343_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY AAFWJ ACPRK ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GX1 JSF JSH KQ8 OK1 RJT RZJ SDH TKC TR2 X7M ZXP AAYXX CITATION CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c470t-f8899c42c89adfa71319d33dfd951c11833ba70941f2ace18f9a999e6c29febc3 |
ISSN | 1349-2365 |
IngestDate | Fri Sep 17 19:08:25 EDT 2021 Thu Apr 24 22:53:51 EDT 2025 Tue Jul 01 00:56:06 EDT 2025 Wed Sep 03 06:11:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c470t-f8899c42c89adfa71319d33dfd951c11833ba70941f2ace18f9a999e6c29febc3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/ihj/55/3/55_13-343/_article/-char/en |
PMID | 24814327 |
PageCount | 7 |
ParticipantIDs | pubmed_primary_24814327 crossref_primary_10_1536_ihj_13_343 crossref_citationtrail_10_1536_ihj_13_343 jstage_primary_article_ihj_55_3_55_13_343_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-00-00 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | International Heart Journal |
PublicationTitleAlternate | Int. Heart J. |
PublicationYear | 2014 |
Publisher | International Heart Journal Association |
Publisher_xml | – name: International Heart Journal Association |
References | 21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90. 8. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of immune response. Immunol Rev 2005; 203: 156-64. (Review) 1. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-12. 14. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7. 22. Hori M, Sasayama S, Kitabatake A, et al; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-30. 18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86. 10. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76: 10-4. (Review) 23. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7. 12. Tang TT, Ding YJ, Liao YH, et al. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 2010; 25: 451-8. 5. Vaduganathan M, Greene SJ, Gheorghiade M, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013; 18: 835-45. 11. Schneider-Hohendorf T, Stenner MP, Wiendl H, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-90. 3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50. 17. Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nature Immunol 2005; 6: 1069-70. 7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. J Immunol 1995; 155: 1151-64. 2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subject. Circulation 1993; 88: 107-15. 15. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5. 6. Yndestad A, Holm AM, Müller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6. 19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8. 4. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C- 8C. (Review) 16. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622-31. 20. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185-93. 25. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302. 13. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12. 24. Anand IS, Latini R, Florea VG, et al; Val-HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-34. 9. Balandina A, Lécart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-41. 22 23 24 25 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 24. Anand IS, Latini R, Florea VG, et al; Val-HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-34. – reference: 11. Schneider-Hohendorf T, Stenner MP, Wiendl H, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-90. – reference: 5. Vaduganathan M, Greene SJ, Gheorghiade M, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013; 18: 835-45. – reference: 15. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5. – reference: 22. Hori M, Sasayama S, Kitabatake A, et al; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-30. – reference: 14. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7. – reference: 9. Balandina A, Lécart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-41. – reference: 18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86. – reference: 25. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302. – reference: 4. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C- 8C. (Review) – reference: 8. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of immune response. Immunol Rev 2005; 203: 156-64. (Review) – reference: 12. Tang TT, Ding YJ, Liao YH, et al. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 2010; 25: 451-8. – reference: 23. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7. – reference: 6. Yndestad A, Holm AM, Müller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6. – reference: 1. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-12. – reference: 3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50. – reference: 20. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185-93. – reference: 10. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76: 10-4. (Review) – reference: 21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90. – reference: 19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8. – reference: 7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. J Immunol 1995; 155: 1151-64. – reference: 17. Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nature Immunol 2005; 6: 1069-70. – reference: 13. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12. – reference: 16. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622-31. – reference: 2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subject. Circulation 1993; 88: 107-15. – ident: 8 doi: 10.1111/j.0105-2896.2005.00231.x – ident: 15 doi: 10.1126/science.1160062 – ident: 20 doi: 10.1016/j.cyto.2009.09.007 – ident: 10 doi: 10.1016/j.jbspin.2008.08.002 – ident: 9 doi: 10.1182/blood-2003-11-3900 – ident: 11 doi: 10.1002/eji.201040558 – ident: 1 doi: 10.1161/01.CIR.0000147611.92021.2B – ident: 2 doi: 10.1161/01.CIR.88.1.107 – ident: 16 doi: 10.4049/jimmunol.176.8.4622 – ident: 5 doi: 10.1007/s10741-012-9352-9 – ident: 7 doi: 10.4049/jimmunol.155.3.1151 – ident: 4 doi: 10.1016/j.amjcard.2005.03.006 – ident: 24 doi: 10.1161/CIRCULATIONAHA.104.508465 – ident: 6 doi: 10.1016/S0008-6363(03)00362-6 – ident: 3 doi: 10.1016/j.jacc.2007.02.037 – ident: 21 doi: 10.1016/S0140-6736(00)04560-8 – ident: 18 doi: 10.1084/jem.20030152 – ident: 19 doi: 10.1038/nature04753 – ident: 17 doi: 10.1038/ni1105-1069 – ident: 22 doi: 10.1016/j.ahj.2003.07.023 – ident: 25 doi: 10.1056/NEJM199108013250501 – ident: 12 doi: 10.1159/000303050 – ident: 13 doi: 10.1161/CIRCULATIONAHA.108.832782 – ident: 14 doi: 10.1536/ihj.52.382 – ident: 23 doi: 10.1093/eurheartj/ehi631 |
SSID | ssj0041507 |
Score | 2.189821 |
Snippet | Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the... |
SourceID | pubmed crossref jstage |
SourceType | Index Database Enrichment Source Publisher |
StartPage | 271 |
SubjectTerms | Aged Echocardiography Follow-Up Studies Heart Failure - blood Heart Failure - immunology Heart Failure - physiopathology Heart Ventricles - diagnostic imaging Heart Ventricles - physiopathology Humans Immunity, Cellular Inflammation Male Prognosis Stroke Volume - physiology T-Lymphocytes, Regulatory - immunology Ventricular Function, Left |
Title | Prognostic Value of Circulating Regulatory T Cells for Worsening Heart Failure in Heart Failure Patients With Reduced Ejection Fraction |
URI | https://www.jstage.jst.go.jp/article/ihj/55/3/55_13-343/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/24814327 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | International Heart Journal, 2014, Vol.55(3), pp.271-277 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1349-3299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0041507 issn: 1349-2365 databaseCode: KQ8 dateStart: 20050101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 1349-3299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0041507 issn: 1349-2365 databaseCode: DIK dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1349-3299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0041507 issn: 1349-2365 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbKQIgXxHWUmyzBC6oyGttpkkdUraomdfShQ32LbMdRs1YNapMH9gf4mfwVji-5dJvQgBercly7yffVPufkXBD6mDIZqkhSb5gFxGOCxB4HPcQLs9AXYhQzIfQb3dn5aHrBzpbBstf71fFaqkpxIq9ujSv5F1ShD3DVUbJ_gWwzKXTAZ8AXWkAY2jthPN8V2k9O51z9xjeVUf_H-U6aklzGrc4Umtev0ReDsdpsTPIFbSDfK2MPmQLPy8GE59o5fWDSXnU75jbpqvaRLVcwW1ppb4HTS2Xri092NiqiK-AeWhjtdGedezHhhz-4LsFidv9q3ZwLX9cceFPYPb9YFy1rV7lOK23G8321ynfNNR2xU9iYoz1f86uqa8XwW_vlH37WDYbaLZqy2CPUVpg4UW0fJbbUUr2v2_S_jr-0u0nboi_uvCe2jMyNoyQwtW7ylfYE9KjNJXUtNbcDPoFBSRAkVDc-TWBwUl_SsXNA1XvoPglBFNLR6MvGB4lpadxYBNwtufy5sPTnduEDienBJSgNOhvEgRJkhKHFE_TYPTn8xS7_FPXU9hl6OHN-Gs_Rz5aZ2DATFxnuMBO3zMQLbJiJgZm4YSY2EGFHRJxvr3XUzMSamdgxE9fMxDUzX6CLyeliPPVcyQ9PsnBYelkE-r9kREYxTzMe-nBCpJSmWQqagARlmFLBw2HM_IxwqfwoizmoOGokSZwpIelLdLQttuoVwvB4xSjI5ChlGZNqyKOQKBpGImWK-oL10af6sSbS5cPXZVk2idaLAQIDq4Wzjz40Y7_bLDC3jootOs2YuxOkj44toM13CYtAlyHh6_-Y9Q16pP9s1mT4Fh2Vu0q9AyG6FO8NEaE9n89-A7R31xM |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Value+of+Circulating+Regulatory+T+Cells+for+Worsening+Heart+Failure+in+Heart+Failure+Patients+With+Reduced+Ejection+Fraction&rft.jtitle=International+Heart+Journal&rft.au=Miyauchi%2C+Yuka&rft.au=Okamoto%2C+Naoko&rft.au=Ishihara%2C+Yasuhiro&rft.au=Kohno%2C+Masakazu&rft.date=2014&rft.pub=International+Heart+Journal+Association&rft.issn=1349-2365&rft.eissn=1349-3299&rft.volume=55&rft.issue=3&rft.spage=271&rft.epage=277&rft_id=info:doi/10.1536%2Fihj.13-343&rft.externalDocID=article_ihj_55_3_55_13_343_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1349-2365&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1349-2365&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1349-2365&client=summon |